v3.26.1
Segment Reporting - Summary of Significant Segment Expenses (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Jul. 31, 2026
Apr. 30, 2026
Jan. 31, 2026
Jul. 31, 2025
Apr. 30, 2025
Jan. 31, 2025
Jul. 31, 2026
Jul. 31, 2025
Research and development expenses:                
Total research and development expenses $ 20,090     $ 22,575     $ 64,540 $ 62,758
General and administrative expenses:                
Other general and administrative expenses 3,091     2,873     10,970 8,394
Total general and administrative expenses 13,924     7,372     32,627 20,926
Other segment items (1,513)     (956)     (4,687) (4,262)
Net loss 32,501 $ 30,227 $ 29,752 28,991 $ 25,815 $ 24,616 92,480 79,422
Chemistry, Manufacturing and Controls                
Research and development expenses:                
Total research and development expenses 4,814     11,278     22,968 30,657
Clinical Operations                
Research and development expenses:                
Total research and development expenses 4,261     4,837     13,426 12,951
Other Research and Development Expenses                
Research and development expenses:                
Total research and development expenses 2,026     1,139     5,426 4,792
Personnel-Related Expenses Excluding Stock-Based Compensation                
Research and development expenses:                
Total research and development expenses 6,877     4,467     17,977 11,991
General and administrative expenses:                
Total general and administrative expenses 5,135     2,772     11,642 7,859
Stock Based Compensation                
Research and development expenses:                
Total research and development expenses 2,112     854     4,743 2,367
General and administrative expenses:                
Total general and administrative expenses $ 5,698     $ 1,727     $ 10,015 $ 4,673